Home › Stocks › PETS › All Fund Holders
PETS — PETMED EXPRESS INC · All Fund Holders
Funds holding (latest): 37 · Reported value held: $14.12M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 963.76K | $3.08M | 0.00% | Hold |
| Renaissance Technologies history | Q2 2026 | 1.13M | $2.17M | 0.00% | Reduce |
| Principal Global Investors history | Q1 2023 | 127.04K | $2.06M | 0.00% | Reduce |
| Balyasny Asset Management history | Q1 2023 | 82.94K | $1.35M | 0.00% | New |
| BlackRock Inc history | Q2 2026 | 568.25K | $1.09M | 0.00% | Add |
| CPP Investments history | Q3 2021 | 25.00K | $672.00K | 0.00% | New |
| PSP Investments history | Q1 2023 | 37.08K | $602.21K | 0.00% | Reduce |
| Geode Capital Management history | Q2 2026 | 204.07K | $391.95K | 0.00% | Reduce |
| BNY Mellon history | Q1 2024 | 70.69K | $338.62K | 0.00% | Reduce |
| Prudential Financial history | Q1 2023 | 20.54K | $333.60K | 0.00% | Reduce |
| Maverick Capital history | Q3 2023 | 27.46K | $281.51K | 0.01% | New |
| UBS Group AG history | Q2 2026 | 138.33K | $265.59K | 0.00% | Reduce |
| Manulife Financial history | Q1 2022 | 8.58K | $221.00K | 0.00% | Reduce |
| AQR Capital Management history | Q1 2025 | 43.92K | $184.04K | 0.00% | Reduce |
| Arrowstreet Capital history | Q2 2026 | 79.50K | $152.65K | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 74.13K | $142.32K | 0.00% | Reduce |
| D. E. Shaw & Co history | Q2 2025 | 33.68K | $111.81K | 0.00% | Reduce |
| Invesco Ltd history | Q3 2025 | 36.08K | $90.56K | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 42.65K | $81.89K | 0.00% | Reduce |
| Goldman Sachs Group history | Q4 2025 | 24.71K | $79.08K | 0.00% | Reduce |
| Two Sigma Investments history | Q3 2024 | 20.39K | $75.03K | 0.00% | Reduce |
| Deutsche Bank AG history | Q1 2024 | 14.89K | $71.32K | 0.00% | Add |
| Millennium Management history | Q1 2025 | 16.85K | $70.61K | 0.00% | Reduce |
| Royce & Associates history | Q3 2024 | 13.41K | $49.34K | 0.00% | Reduce |
| Marshall Wace history | Q2 2024 | 11.37K | $46.06K | 0.00% | New |
| Point72 Asset Management history | Q2 2023 | 1.92K | $26.41K | 0.00% | New |
| Charles Schwab Investment Management history | Q1 2026 | 10.07K | $22.95K | 0.00% | Hold |
| Morgan Stanley history | Q2 2026 | 11.60K | $22.28K | 0.00% | Add |
| JPMorgan Chase & Co history | Q3 2025 | 5.85K | $14.69K | 0.00% | Reduce |
| Legal & General Investment Management America history | Q1 2024 | 1.71K | $8.20K | 0.00% | Reduce |
| Amundi US history | Q3 2023 | 734 | $7.12K | 0.00% | Hold |
| Bank of America Corp history | Q4 2025 | 746 | $2.39K | 0.00% | Hold |
| Wells Fargo & Co history | Q2 2026 | 300 | $577 | 0.00% | Hold |
| T. Rowe Price Associates history | Q2 2026 | 129.93K | $250 | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 60 | $115 | 0.00% | Reduce |
| PNC Financial Services history | Q2 2025 | 22 | $73 | 0.00% | Hold |
| Citigroup Inc history | Q2 2026 | 9 | $17 | 0.00% | Reduce |